Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Spartan Bioscience, Inc. Receives Frost & Sullivan Global Award - 2008 Global Polymerase Chain Reaction Product of the Year Award goes to the Spartan DXTM DNA analyser
Spartan Bioscience, Inc. Receives Frost & Sullivan Global Award


PRZOOM - /newswire/ - Ottawa, Ontario, Canada, 2008/03/25 - 2008 Global Polymerase Chain Reaction Product of the Year Award goes to the Spartan DXTM DNA analyser.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


The 2008 Frost & Sullivan Global Polymerase Chain Reaction Product of the Year Award has been awarded to Spartan Bioscience Inc., a Canadian molecular diagnostics company. The company is recognised for its pioneering Spartan DXTM DNA analyser. This innovative, portable DNA analyser designed for the molecular biology market is aimed at small scale, on-demand DNA analysis. With a unique value proposition in the research and clinical markets, Spartan's innovative product offering is poised to experience widespread market acceptance.

"The Spartan DX DNA analyser finds an exclusive place in the molecular biology market as the need for small scale DNA analysis is yet to be fulfilled," notes Frost & Sullivan Research Analyst Arun A.K. "With strong qualitative results, this portable DNA analyser represents a major breakthrough in polymerase chain reaction (PCR) technology."

Launched in June 2007, the Spartan DXTM DNA analyser is a portable and compact analyser that has been designed for non-batched, on-demand DNA applications with a major focus on convenience and affordability. A perfect match for low throughput analysis, this analyser is a boon for researchers and clinicians as it addresses the need for small scale analysis as a complement to the batched PCR workflows that dominate the industry.

This product gives Spartan the competitive edge as it enjoys first mover advantage in the small volume analyser market. The Spartan DX DNA analyser has already received positive feedback from its customers within a short period of its launch.

Clients have lauded the analyser as being an ideal fit for bacterial microbiology laboratories in developing nations as it is relatively inexpensive. Moreover, it has been commended for being compact, easy-to-use, giving results faster than most PCR instruments, and being well-suited for analysing single samples. As such, the Spartan DX is extremely effective for occasional STAT testing: the analysis of occasional but important 'rush' specimens that fall outside the routine testing schedule of the diagnostic virology laboratory.

"After having been successfully introduced in research labs in Canada and the USA, Spartan Bioscience is now actively exploring broader global markets to expand its presence," states Arun. "With an expanding distribution network, Spartan Bioscience is preparing to revolutionise the PCR market with its first-to-market, on-demand DNA analyser."

The Frost & Sullivan Award for Product of the Year is presented each year to the company that has demonstrated excellence in new product development and launch within its industry. The recipient company has shown innovation by its plans to launch a broad line of emerging products and technologies.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Spartan Bioscience
Spartan Bioscience Inc. ( is a privately-held molecular diagnostics company that develops, manufactures, and markets Polymerase Chain Reaction (PCR) DNA analysers for on-demand applications. The company is focusing on applications where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments and non-batched testing for infectious diseases.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Spartan Bioscience, Inc. Receives Frost & Sullivan Global Award

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Jasmine Malone 
+44 207 915 7869 jasmine.malone[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From Frost & Sullivan / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy
Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit
Frost & Sullivan Highlights argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPL
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...


Visit  Intrinsic Executive Search Ltd

Visit  NAKIVO, Inc.


  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today